X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-22 | MDT | Jellison William R | Dir | P - Purchase | $92.55 | +5,000 | 5,000 | New | +$462,750 | |||||
| D | 2025-01-24 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale+OE | $90.00 | -12,437 | 40,979 | -23% | -$1,119,330 | |||||
| D | 2025-01-08 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale+OE | $80.41 | -9,850 | 40,708 | -19% | -$792,039 | |||||
| D | 2024-06-07 | MDT | Martha Geoffrey | COB, CEO | S - Sale+OE | $83.77 | -19,113 | 143,348 | -12% | -$1,601,001 | |||||
2024-04-08 | MDT | Marinaro Michael | EVP, Pres, Surgical OU | S - Sale | $83.14 | -854 | 27,925 | -3% | -$71,002 | ||||||
| D | 2024-02-21 | MDT | Salmon Sean | EVP, Pres Cardiovascular | S - Sale+OE | $85.13 | -30,695 | 48,289 | -39% | -$2,613,055 | |||||
2023-12-19 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale | $82.17 | -4,997 | 28,910 | -15% | -$410,603 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |